Endoscopic Ultrasound-Guided Local Therapy for Pancreatic Neoplasms [PDF]
Clinical Endoscopy, 2020 Surgical resection is considered the only treatment option for pancreatic cancer and other pancreatic neoplasms with malignant potential, such as neuroendocrine tumors, mucinous cystic neoplasms, and intraductal papillary mucinous neoplasms.
Jun Seong Hwang +2 more
doaj +3 more sources
Current Status of Endoscopic Ultrasound Techniques for Pancreatic Neoplasms [PDF]
Clinical Endoscopy, 2019 Endoscopic ultrasound (EUS) now plays an important role in the management of pancreatic neoplasms. There are various types of pancreatic neoplasms, from benign to malignant lesions, and the role of EUS ranges from the imaging diagnosis to treatment.
Yousuke Nakai +4 more
doaj +3 more sources
Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms [PDF]
BMC Complementary and Alternative Medicine, 2019 Background Wumei Pill (WMP), a famous herbal formula, has been widely used to treat digestive system diseases in clinical practice in China for centuries.
Yuxiang Wan +6 more
doaj +3 more sources
Background features in the cytology of pancreatic neoplasms [PDF]
DEN Open, 2022 Cytology is a useful method for diagnosing pancreatic neoplasms. Although endoscopic ultrasound‐guided fine‐needle aspiration has recently become the mainstream method for the diagnosis of pancreatic neoplasms, pancreatic juice and pancreatic duct ...
Kenichi Hirabayashi +2 more
doaj +2 more sources
Imaging of Pancreatic Neuroendocrine Neoplasms [PDF]
International Journal of Environmental Research and Public Health, 2021 Pancreatic neuroendocrine neoplasms (panNENs) represent the second most common pancreatic tumors. They are a heterogeneous group of neoplasms with varying clinical expression and biological behavior, from indolent to aggressive ones. PanNENs can be functioning or non-functioning in accordance with their ability or not to produce metabolically active ...
Giuditta Chiti +9 more
openaire +6 more sources
Recent Advances in Pancreatic Neoplasms. [PDF]
J Clin Med, 2021 Pancreatic neoplasms, both primary and secondary, include different pathological entities with variable biological behavior and, consequently, different treatment modalities [...]
Sperti C, Serafini S, Moletta L.
europepmc +4 more sources
Journal of Minimal Access Surgery, 2023 Introduction: The efficacy and safety of minimally invasive pancreatic enucleation (PE) have rarely been investigated. This study aimed to compare the perioperative and long-term outcomes of minimally invasive enucleation (MIEn) with those of open ...
Zhihao Huang +6 more
doaj +2 more sources
Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy [PDF]
BMC Cancer, 2020 Background Invasive pancreatic neoplasms have a high propensity for recurrence even after curative resection. Recently, patients who underwent pancreatectomy have an opportunity of undergoing secondary pancreatic resection, so-called “repeat ...
Shigetsugu Takano +11 more
doaj +2 more sources
Surgical and molecular pathology of pancreatic neoplasms. [PDF]
Diagn Pathol, 2016 BackgroundHistologic characteristics have proven to be very useful for classifying different types of tumors of the pancreas. As a result, the major tumor types in the pancreas have long been classified based on their microscopic appearance.Main ...
Hackeng WM +3 more
europepmc +2 more sources
Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis. [PDF]
Oncol Lett, 2017 Aberrant expression of Beclin 1 and B-cell lymphoma-2 (Bcl-2) has been identified in a variety of human tumors; however, little information is available for pancreatic neoplasms.
Song S, Wang B, Gu S, Li X, Sun S.
europepmc +2 more sources